Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

for
Atherosclerosis
Location: Dallas TX, Houston TX, San Antonio TX, St Louis MO,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07448038

Phase2, Recruiting
Featured

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Fort Worth TX, Dallas TX, Garland TX, Tyler TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase3, Recruiting
Featured

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

for
Primary Open Angle Glaucoma
Location: Dallas TX, Oklahoma City OK, Houston TX, New Orleans LA,
Sponsor: AbbVie

Sex: All

Age: 45+

Code: NCT06822738

Phase3, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Dallas TX, Charlotte NC, Ann Arbor MI,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06953960

Phase1, Phase2, Recruiting
Featured

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

for
Ulcerative Colitis
Location: Dallas TX, Atlanta GA, Chicago IL, Greenville SC,
Sponsor: AbbVie

Sex: All

Age: 2 - 17

Code: NCT07071519

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Dallas TX, Nashville TN, Valhalla NY, Palo Alto CA
Sponsor: AbbVie

Sex: All

Age: 0 - 17

Code: NCT07306832

Phase1, Recruiting
Featured

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair

for
Ventral Hernia
Location: Dallas TX, Pensacola FL, Rochester MN, Evanston IL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07226791

Phase2, Recruiting
Featured

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Dallas TX, Tyler TX, Austin TX, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05650632

Phase1, Recruiting
Featured

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer
Location: Dallas TX, Tyler TX, Little Rock AR, Lincoln NE,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06568939

Phase2, Recruiting
Featured

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

for
Breast Cancer
Location: Dallas TX, St Louis MO, Nashville TN, Atlanta GA,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07100106

Phase1, Phase2, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Dallas TX, Round Rock TX, Tulsa OK, Memphis TN,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase3, Recruiting
Featured

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

for
Systemic Lupus Erythematosus, Rheumatoid Arthritis
Location: Red Oak TX, Jackson TN, Anniston AL, Orland Park IL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07607964

Phase1, Recruiting
Featured

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

for
Diabetic Retinopathy
Location: Dallas TX, Burleson TX, Austin TX, Lenexa KS,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07592273

Phase2, Phase3, Recruiting
Featured

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

for
Alzheimer's Disease
Location: Dallas TX, Cordova TN, Boulder CO, Lady Lake FL,
Sponsor: AbbVie

Sex: All

Age: 50 - 70+

Code: NCT07599670

Phase1, Phase2, Recruiting
Featured

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for
Neovascular Age-related Macular Degeneration
Location: Burleson TX, Round Rock TX, Abilene TX, Austin TX,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07007065

Phase3, Recruiting
Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Dallas TX, Norman OK, Oklahoma City OK, Tomball TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase3, Recruiting
Featured

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Dallas TX, Longview TX, Austin TX, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase2, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

for
Schizophrenia
Location: Richardson TX, Austin TX, Little Rock AR,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07145918

Phase2, Recruiting
Featured

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

for
Chronic Migraine
Location: Waxahachie TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: AbbVie

Sex: All

Age: 12 - 17

Code: NCT06810505

Phase3, Recruiting
Featured

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

for
Episodic Migraine
Location: Waxahachie TX, Austin TX, Oklahoma City OK,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05711394

Phase3, Recruiting